{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:09:59Z","timestamp":1768216199131,"version":"3.49.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Amyotrophic lateral sclerosis (ALS) is a progressive, age-related motor neuron degenerative disease with multiple causal factors. Dyslipidemia has been identified as an important pathological element. Impaired lipid protein metabolism manifests in ALS patients and in an ALS mouse model. Apolipoprotein components are the primary regulators of plasma lipid metabolism. Apolipoprotein A1 (ApoA1), a high-density lipoprotein, acts as an antioxidant and reduces inflammation, preventing blood vessel injury. However, the effects of ApoA1 upon the ALS-damaged endothelium in the CNS are unknown. The objective of the study was to determine the effect(s) of injecting ApoA1 into G93A SOD1 mice at the early symptomatic stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single dose of ApoA1 or media was systemically administered into 13-week-old G93A SOD1 male and female mice. Body weight and tests of motor function were evaluated weekly for 4\u202fweeks post-injection. Permeability of spinal cord capillaries was determined by Evans blue (EB) fluorescent dye injected into mice at 17\u202fweeks of age. Immunohistochemical analyses determined the statuses of glial cells and ApoA1 distributions in ALS mice cervical\/lumbar spinal cords. Motor neurons in cervical\/lumbar spinal cord ventral horns of ApoA1-treated and media-injected ALS mice were stained with cresyl violet for histological analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ApoA1 injected into G93A SOD1 mice at the early symptomatic stage significantly benefited both male and female animals by (1) delaying behavioral disease progression; (2) reducing EB capillary leakage into spinal cord parenchyma; (3) lessening astrogliosis and microgliosis; (4) protein incorporation into capillary endothelium and motor neurons; and (5) improving survival of motor neurons in the spinal cord.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our novel data showed that systemically administered ApoA1 benefited ALS mice of both sexes, likely by beneficial effects on damaged microvessels, possibly engendering restoration of neurovascular unit integrity. Moreover, an anti-inflammatory ApoA1 effect was demonstrated by the reduction of glial cell activation, potentially mitigating vascular injury. The results of our preclinical study suggest that ApoA1 may be a potential protein-mediated therapeutic for restoring vascular function. Our novel strategy may lead to future clinical trials, furthering our goal of effectively treating ALS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2025.1684694","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:38Z","timestamp":1768205618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Apolipoprotein A1 reduces blood\u2013spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice"],"prefix":"10.3389","volume":"17","author":[{"given":"Svitlana","family":"Garbuzova-Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larai","family":"Manora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesario V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/ATVBAHA.122.318196","article-title":"ApoA-I nanotherapy rescues postischemic vascular maladaptation by modulating endothelial cell and macrophage phenotypes in type 2 diabetic mice","volume":"43","author":"Babu","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2009.01.004","article-title":"Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review","volume":"206","author":"Benn","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","article-title":"Leveraging knowledge of HDLs major protein ApoA1: structure, function, mutations, and potential therapeutics","volume":"154","author":"Bhale","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1007\/s00415-024-12665-x","article-title":"Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study","volume":"271","author":"Chalitsios","year":"2024","journal-title":"J. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","article-title":"Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis","volume":"9","author":"Chaves-Filho","year":"2019","journal-title":"Sci. Rep."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/21678421.2020.1832119","article-title":"Dyslipidemia in patients with amyotrophic lateral sclerosis\u2014a case control retrospective study","volume":"22","author":"Che\u0142stowska","year":"2021","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11883-021-00906-7","article-title":"APOA1: a protein with multiple therapeutic functions","volume":"23","author":"Cochran","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood-2007-03-078709","article-title":"Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA","volume":"110","author":"Deregibus","year":"2007","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.3390\/ijms22179553","article-title":"A transcriptomic Meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of SOD1 mice","volume":"22","author":"Fern\u00e1ndez-Beltr\u00e1n","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"ENEURO.0314-21.2021","DOI":"10.1523\/ENEURO.0314-21.2021","article-title":"Beneficial effects of transplanted human bone marrow endothelial progenitors on functional and cellular components of blood-spinal cord barrier in ALS mice","volume":"8","author":"Garbuzova-Davis","year":"2021","journal-title":"eNeuro"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.expneurol.2018.08.012","article-title":"Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair","volume":"310","author":"Garbuzova-Davis","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"","journal-title":"Brain Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1038\/s41598-019-41747-4","article-title":"Human bone marrow endothelial progenitor cell transplantation into symptomatic ALS mice delays disease progression and increases motor neuron survival by repairing blood-spinal cord barrier","volume":"9","author":"Garbuzova-Davis","year":"2019","journal-title":"Sci. Rep."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41598-017-00993-0","article-title":"Endothelial and astrocytic support by human bone marrow stem cell grafts into symptomatic ALS mice towards blood-spinal cord barrier repair","volume":"7","author":"Garbuzova-Davis","year":"2017","journal-title":"Sci. Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","article-title":"Amyotrophic lateral sclerosis: a neurovascular disease","volume":"1398","author":"Garbuzova-Davis","year":"2011","journal-title":"Brain Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1371\/journal.pone.0001205","article-title":"Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS","volume":"2","author":"Garbuzova-Davis","year":"","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"ENEURO.0140-22.2022","DOI":"10.1523\/ENEURO.014022.2022","article-title":"Apolipoprotein A1 enhances endothelial cell survival in an in vitro model of ALS","volume":"9","author":"Garbuzova-Davis","year":"2022","journal-title":"eNeuro"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fneur.2019.00284","article-title":"Lipid biomarkers for amyotrophic lateral sclerosis","volume":"10","author":"Gonz\u00e1lez De Aguilar","year":"2019","journal-title":"Front. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","article-title":"Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS","volume":"72","author":"Henkel","year":"2009","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s40142-017-0123-8","article-title":"Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities","volume":"5","author":"Joardar","year":"2017","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e033541","DOI":"10.1161\/JAHA.123.033541","article-title":"CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-to-lymphocyte ratio induced by acute myocardial infarction","volume":"13","author":"Kingwell","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/01.ATV.0000091338.93223.E8","article-title":"Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress","volume":"23","author":"Kontush","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00041433-200404000-00009","article-title":"Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity","volume":"15","author":"Koschinsky","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1748-1716.2011.02256.x","article-title":"The neurovascular unit in brain function and disease","volume":"203","author":"Lecrux","year":"2011","journal-title":"Acta Physiol (Oxf.)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","article-title":"Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice","volume":"590","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/cells13050435","article-title":"Cellular and noncellular approaches for repairing the damaged blood-CNS-barrier in amyotrophic lateral sclerosis","volume":"13","author":"Manora","year":"2024","journal-title":"Cells"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21678421.2021.1949021","article-title":"Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016","volume":"23","author":"Mehta","year":"2022","journal-title":"Amyotrophic Lateral Scler. Frontotemporal Degener."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1248\/bpb.b15-00716","article-title":"Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis","volume":"39","author":"Morita","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bbalip.2016.03.022","article-title":"A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells","volume":"1861","author":"Pan","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2007.05.008","article-title":"Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo","volume":"196","author":"Puranik","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"7908","DOI":"10.3390\/ijms26167908","article-title":"Apolipoprotein a (ApoA) in neurological disorders: connections and insights","volume":"26","author":"Rajha","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.120.316848","article-title":"Apo AI nanoparticles delivered post myocardial infarction moderate inflammation","volume":"127","author":"Richart","year":"2020","journal-title":"Circ. Res."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/01.cir.97.8.780","article-title":"Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein Edeficient mice","volume":"97","author":"Shah","year":"1998","journal-title":"Circulation"},{"key":"ref41","first-page":"989","article-title":"Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis","volume":"11","author":"Smith","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbrc.2017.09.072","article-title":"Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity","volume":"493","author":"Svensson","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1417270","DOI":"10.3389\/fimmu.2024.1417270","article-title":"Anti-inflammatory mechanism of apolipoprotein A-I","volume":"15","author":"Tao","year":"2024","journal-title":"Front. Immunol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.metabol.2018.06.002","article-title":"HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K\/AKT\/FOXO1 signaling pathway","volume":"87","author":"Theofilatos","year":"2018","journal-title":"Metab. Clin. Exp."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jnnp-2021-327133","article-title":"Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis","volume":"93","author":"Thompson","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-3-030-41769-7_16","article-title":"High-density lipoproteins and apolipoprotein A1","volume-title":"Vertebrate and invertebrate respiratory proteins, lipoproteins and other body fluid proteins","author":"van der Vorst","year":"2020"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5772\/47869","article-title":"The apoB\/apoA-1 ratio is a strong predictor of cardiovascular risk","volume-title":"Lipoproteins: role in health and diseases","author":"Walldius","year":"2012"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2014a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1515\/CCLM.2004.254","article-title":"The apoB\/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk","volume":"42","author":"Walldius","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1194\/jlr.M004549","article-title":"Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung","volume":"51","author":"Wang","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/ene.15810","article-title":"Lipids and amyotrophic lateral sclerosis: a two-sample Mendelian randomization study","volume":"30","author":"Xia","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"4610834","DOI":"10.1155\/2022\/4610834","article-title":"Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives","volume":"2022","author":"Xu","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.lfs.2006.02.011","article-title":"Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice","volume":"79","author":"Yan","year":"2006","journal-title":"Life Sci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fnins.2020.00334","article-title":"Neurovascular unit dysfunction and neurodegenerative disorders","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat. Neurosci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1177\/0271678X231172008","article-title":"The neurovascular unit in healthy and injured spinal cord","volume":"43","author":"Zhou","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1684694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:13:40Z","timestamp":1768205620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1684694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":57,"alternative-id":["10.3389\/fnagi.2025.1684694"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1684694","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1684694"}}